Price of Pfizer's smoking-cessation drug Chantix doubles in just 5 years: report

26th June 2018 Uncategorised 0

Pfizer’s smoking-cessation drug Chantix nudged closer to blockbuster status last year, bringing in $997 million in sales—up 18% from 2016. But some portion of that gain apparently came from price hikes, judging from a new report.

More: Price of Pfizer's smoking-cessation drug Chantix doubles in just 5 years: report
Source: fierce